Iberdomide plus dexamethasone in heavily pretreated late-line relapsed or refractory multiple myeloma (CC-220-MM-001): a multicentre, multicohort, open-label, phase 1/2 trial
Titel:
Iberdomide plus dexamethasone in heavily pretreated late-line relapsed or refractory multiple myeloma (CC-220-MM-001): a multicentre, multicohort, open-label, phase 1/2 trial
Auteur:
Lonial, Sagar Popat, Rakesh Hulin, Cyrille Jagannath, Sundar Oriol, Albert Richardson, Paul G Facon, Thierry Weisel, Katja Larsen, Jeremy T Minnema, Monique C Abdallah, Al-Ola Badros, Ashraf Z Knop, Stefan Stadtmauer, Edward A Cheng, Yiming Amatangelo, Michael Chen, Min Nguyen, Tuong Vi Amin, Alpesh Peluso, Teresa van de Donk, Niels W C J